Thrivent Financial for Lutherans Trims Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Thrivent Financial for Lutherans cut its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 2.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 59,704 shares of the real estate investment trust’s stock after selling 1,763 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Omega Healthcare Investors were worth $2,045,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of OHI. Sei Investments Co. grew its stake in Omega Healthcare Investors by 150.8% in the 2nd quarter. Sei Investments Co. now owns 298,761 shares of the real estate investment trust’s stock worth $10,233,000 after acquiring an additional 179,623 shares during the period. Pacer Advisors Inc. boosted its holdings in shares of Omega Healthcare Investors by 28.7% during the second quarter. Pacer Advisors Inc. now owns 47,704 shares of the real estate investment trust’s stock worth $1,634,000 after purchasing an additional 10,643 shares during the last quarter. AE Wealth Management LLC purchased a new stake in shares of Omega Healthcare Investors in the second quarter valued at $293,000. Canada Pension Plan Investment Board acquired a new position in Omega Healthcare Investors in the second quarter valued at $4,692,000. Finally, Intech Investment Management LLC purchased a new position in Omega Healthcare Investors during the second quarter worth about $2,104,000. Institutional investors and hedge funds own 65.25% of the company’s stock.

Analysts Set New Price Targets

Several analysts have commented on the company. Scotiabank lifted their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Wells Fargo & Company restated an “overweight” rating and issued a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday. Mizuho downgraded shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and increased their price target for the stock from $34.00 to $35.00 in a research note on Thursday, July 25th. Finally, Truist Financial lifted their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Eight research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $35.78.

Omega Healthcare Investors Stock Down 0.8 %

Shares of NYSE OHI opened at $40.39 on Wednesday. The stock has a fifty day moving average price of $38.88 and a 200 day moving average price of $34.47. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19. Omega Healthcare Investors, Inc. has a 12-month low of $27.53 and a 12-month high of $41.53. The company has a market cap of $9.98 billion, a P/E ratio of 36.38, a P/E/G ratio of 1.32 and a beta of 1.00.

Omega Healthcare Investors (NYSE:OHI) last posted its earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). The company had revenue of $252.70 million during the quarter, compared to analyst estimates of $205.92 million. Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. Omega Healthcare Investors’s quarterly revenue was up 17.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.74 EPS. Research analysts anticipate that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Monday, August 5th were given a dividend of $0.67 per share. The ex-dividend date was Monday, August 5th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.64%. Omega Healthcare Investors’s payout ratio is currently 241.44%.

Insider Activity

In related news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.